Results 231 to 240 of about 60,263 (313)

Secretion of Peanut Protein With IgE Crosslinking Capacity in Human Milk

Allergy, Volume 81, Issue 3, Page 861-873, March 2026.
Food proteins from peanut, egg, and cow's milk were detected in human milk with variable kinetics. Ara h 2 in human milk was capable of IgE‐crosslinking, as demonstrated with the basophil activation test. Higher levels of peanut protein, Ara h 2, were found in atopic mothers compared to non‐atopic mothers.
Amy D. Burris, Nichole Diaz, Jon B. Meddings, Bijoya Karmakar, Tarun Keswani, Sarita U. Patil, Antti E. Seppo, Kirsi M. Järvinen   +7 more
wiley   +1 more source

Visual screening and efficacy evaluation of high-performance fluorescent probe DAF-FM in esophagitis cancer transformation. [PDF]

World J Gastrointest Surg
Chen WH, Cai CF, Gao BZ, Hong WS, Xu YZ, Cai WJ.   +5 more
europepmc   +1 more source

Bidirectional Associations Between Seborrheic Dermatitis and Epithelial Barrier Diseases: A Retrospective Cohort Study

Allergy, Volume 81, Issue 3, Page 808-817, March 2026.
This study explores the bidirectional associations between SD and EBDs in a cohort of 5,083,689 individuals in a US administrative claims database. Positive bidirectional associations were found between SD and many EBDs of the skin, respiratory, gastrointestinal, and ocular surfaces. Our results support the EBT as a shared driver of EBD pathogenesis at
Sabrina Meng, Ronald Berna, Junko Takeshita, Ole Hoffstad, Daniel Shin, Nandita Mitra, David J. Margolis   +6 more
wiley   +1 more source

Concurrent Esophageal Intramural Pseudodiverticulosis and Eosinophilic Esophagitis Complicated by Esophageal Perforation. [PDF]

ACG Case Rep J
Nguyen HT, Oroian T.
europepmc   +1 more source

Acid peptic disorder compass: An Indian expert consensus on comprehensive management. [PDF]

World J Gastrointest Pharmacol Ther
Sinha SK, Kochhar R, Rao KS, Yadav D, Ray S, Singh AP, Sethy PK, Mahajan R, Reddy DV, Sharma VM, Kumar A, Mishra A, Jain S, Swami OC, Patil D.   +14 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, Volume 183, Issue 6, Page 1271-1287, March 2026.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Risk of developing eosinophilic esophagitis with preexisting asthma, allergic rhinitis, atopic dermatitis, or food allergy. [PDF]

Allergy Asthma Proc
Haber C, Al-Shaikhly T, Jhaveri P.
europepmc   +1 more source

Trial of Preemptive Pharmacogenetic Testing in Underserved Patients (TOPP UP): Study Framework and Baseline Characteristics of Randomized Controlled Trial Participants

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Research in pharmacogenetics has advanced over the years, but its broad clinical implementation remains limited. While medically underserved patients may particularly benefit from preemptive pharmacogenetic testing, its clinical impact in this population has not been well explored.
Angel M. Miranda, Christelle Lteif, Irina Fofanova, Brian E. Gawronski, Erica N. Elwood, Madeline L. Norris, Emily J. Cicali, Ramzi G. Salloum, Khoa A. Nguyen, Ross E. Jones, Grant Harrell, John Z. Malaty, Larisa H. Cavallari, Julio D. Duarte   +13 more
wiley   +1 more source

Eosinophilic esophagitis in children: Clinical perspectives and evolving therapeutic strategies. [PDF]

World J Gastrointest Endosc
Samanta A, Singh V, Chakraborty B, Ray G.   +3 more
europepmc   +1 more source

Reliability and quality of reflux esophagitis educational videos on TikTok and Bilibili: A cross-sectional study. [PDF]

Medicine (Baltimore)
Deng Z, Xie Y, Wang S, Huang L.
europepmc   +1 more source